KPL MTF Data: Margin Funding in Kwality Pharmaceuticals Limited

₹24.02 Cr +₹21.6 L on the day +9.4% in a month

Kwality Pharmaceuticals Limited has ₹24.02 crore financed under MTF, 0.69% of its shares. The book is up 9.4% in a month. At the last close the financed shares were worth 13.4% more than the amount financed.

22 Oct 2026 NSE + BSE Cash only Healthcare · Pharmaceuticals & Biotechnology #969 by MTF book
Compare Stock page
₹24.02 Cr
MTF book
NSE ₹22.75 Cr · BSE ₹1.27 Cr
71,300
Shares financed (NSE)
1 month +5.5% · 1 year —
₹3,190.87
Average financed value / share
close ₹3,618.30
+13.4%
Financed shares vs amount financed
what margin holders are up or down at the close
0.69%
Of all shares on margin
market cap ₹3,754 Cr
1.7 days
Days to cover
shares financed ÷ 30-day average NSE volume
27.3%
Exchange margin (VaR + ELM)
cushion +40.7 pp after holders' gain/loss
3.7%
Net new MTF shares vs delivery
last 20 sessions, as a share of delivered volume

KPL MTF book and price

Daily for the last two years, weekly before that. The book is the exchange-reported amount financed.

Holders' cost vs the market

Amount financed ÷ shares financed approximates the average price margin holders paid. When the close is below that line, margin holders are, on average, sitting on a loss.

Shares financed

Share counts move only when margin holders buy or sell (and on splits and bonuses), not with the price.

Net new margin buying, by month

Each day's change in shares financed valued at that day's close, summed by month: buying and selling on margin without the effect of price. Split and bonus credits are removed.

Leverage and days to cover

Share of the company's shares on margin (month end) and how many days of average NSE volume they equal.

Records & stats

Latest book₹24.02 Cr
Flow: 1 / 5 / 20 sessions+₹21.6 L · +₹1.11 Cr · +₹1.07 Cr
Change: 1 week / 1 month / 3 months / 1 year+4.8% · +9.4% · +52.5% · —
All-time high₹31.35 Cr 10 Sep 2026
Low since first funded₹3.4 L 23 Mar 2026
Biggest one-day build+₹4.57 Cr 30 Jun 2026
Biggest one-day unwind−₹3.49 Cr 16 Sep 2026
Below its peak23.4%
Average book while funded₹11.56 Cr
Most shares financed96,467 10 Sep 2026
Funded since12 Mar 2026 (150 sessions with a book)

Month by month

MonthBookNet buying% of sharesDays to cover
2026-10₹24.02 Cr+₹32.9 L0.69%2.4
2026-09₹23.16 Cr−₹3.13 Cr0.68%1.5
2026-08₹25.60 Cr+₹8.46 Cr0.77%0.9
2026-07₹15.85 Cr+₹3.88 Cr0.51%2.3
2026-06₹11.43 Cr+₹9.86 Cr0.37%0.9
2026-05₹92.5 L−₹31.5 L0.00%0.0
2026-04₹85.8 L+₹29.3 L0.02%0.1
2026-03₹39.2 L—0.00%—

Questions

How much margin trading funding does KPL have?

On 22 Oct 2026, ₹24.02 Cr of Kwality Pharmaceuticals Limited shares were held under the margin trading facility, 71,300 shares on NSE.

What share of KPL is bought on margin?

About 0.69% of all its shares.

Are margin holders of KPL in profit?

At the last close the financed shares were worth 13.4% more than the amount financed. The amount financed reflects purchase values, so this is an estimate of margin holders' average unrealised gain or loss.

Where does this data come from?

Exchange data: the daily margin trading disclosures, with prices and share counts from the exchange. See the methodology.

Figures for the 22 Oct 2026 session · last updated 2026-10-26 20:38 IST · Source: Exchange data · 10/10 data checks passed.

How to read this page. Everything here describes what the exchanges have already disclosed about margin-funded (MTF) positions. It is not a forecast, a recommendation, or a signal to buy or sell. Words such as "crowded", "fragile" or "underwater" name a pattern in the numbers, nothing more. Margin funding carries the risk of losses larger than the money you put in.

Flash Finance is not a SEBI-registered investment adviser and is not affiliated with NSE, BSE or SEBI. Exchange data may be revised by the exchange. Verify anything you intend to act on against the exchange's own records.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI